Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19.

Nishant ShekharHarpinder KaurPhulen Sarma Ajay Prakash Bikash Medhi

Published in: Expert review of anti-infective therapy (2021)

Indomethacin has demonstrated excellent clinical endpoint characteristics in several studies, and we recommend that it be utilized in the treatment of mild-to-moderate COVID patients.

Keyphrases

sars cov
coronavirus disease
candida albicans
replacement therapy
smoking cessation